nodes	percent_of_prediction	percent_of_DWPC	metapath
Omeprazole—CYP2C18—Ifosfamide—testicular cancer	0.121	0.162	CbGbCtD
Omeprazole—ABCC3—Cisplatin—testicular cancer	0.0643	0.0865	CbGbCtD
Omeprazole—ABCC3—Etoposide—testicular cancer	0.0632	0.085	CbGbCtD
Omeprazole—ABCG2—Dactinomycin—testicular cancer	0.046	0.0619	CbGbCtD
Omeprazole—ABCC3—Doxorubicin—testicular cancer	0.0431	0.058	CbGbCtD
Omeprazole—ABCC3—Methotrexate—testicular cancer	0.0418	0.0561	CbGbCtD
Omeprazole—CYP1B1—Doxorubicin—testicular cancer	0.0373	0.0501	CbGbCtD
Omeprazole—ABCG2—Carboplatin—testicular cancer	0.0309	0.0416	CbGbCtD
Omeprazole—CYP2C8—Ifosfamide—testicular cancer	0.0289	0.0389	CbGbCtD
Omeprazole—ABCG2—Cisplatin—testicular cancer	0.0264	0.0355	CbGbCtD
Omeprazole—ABCG2—Etoposide—testicular cancer	0.026	0.0349	CbGbCtD
Omeprazole—CYP2C19—Ifosfamide—testicular cancer	0.0243	0.0326	CbGbCtD
Omeprazole—CYP11A1—corpus luteum—testicular cancer	0.0232	0.371	CbGeAlD
Omeprazole—CYP2C9—Ifosfamide—testicular cancer	0.0202	0.0271	CbGbCtD
Omeprazole—CYP11A1—seminiferous tubule of testis—testicular cancer	0.0197	0.314	CbGeAlD
Omeprazole—ABCG2—Doxorubicin—testicular cancer	0.0177	0.0238	CbGbCtD
Omeprazole—ABCG2—Methotrexate—testicular cancer	0.0172	0.0231	CbGbCtD
Omeprazole—ABCB1—Dactinomycin—testicular cancer	0.0166	0.0223	CbGbCtD
Omeprazole—CYP2C8—Etoposide—testicular cancer	0.0138	0.0186	CbGbCtD
Omeprazole—CYP3A4—Ifosfamide—testicular cancer	0.0117	0.0158	CbGbCtD
Omeprazole—CYP1A2—Etoposide—testicular cancer	0.0107	0.0144	CbGbCtD
Omeprazole—ABCB1—Vinblastine—testicular cancer	0.0104	0.014	CbGbCtD
Omeprazole—CYP2C9—Cisplatin—testicular cancer	0.00982	0.0132	CbGbCtD
Omeprazole—CYP2D6—Vinblastine—testicular cancer	0.00979	0.0132	CbGbCtD
Omeprazole—ABCB1—Cisplatin—testicular cancer	0.00953	0.0128	CbGbCtD
Omeprazole—ABCB1—Etoposide—testicular cancer	0.00936	0.0126	CbGbCtD
Omeprazole—ABCB1—Doxorubicin—testicular cancer	0.00639	0.00859	CbGbCtD
Omeprazole—CYP3A4—Vinblastine—testicular cancer	0.00623	0.00837	CbGbCtD
Omeprazole—ABCB1—Methotrexate—testicular cancer	0.00619	0.00832	CbGbCtD
Omeprazole—CYP2D6—Doxorubicin—testicular cancer	0.00602	0.00809	CbGbCtD
Omeprazole—CYP3A4—Etoposide—testicular cancer	0.00561	0.00754	CbGbCtD
Omeprazole—CYP3A4—Doxorubicin—testicular cancer	0.00383	0.00514	CbGbCtD
Omeprazole—ATP4A—testis—testicular cancer	0.00183	0.0292	CbGeAlD
Omeprazole—CYP11A1—gonad—testicular cancer	0.00167	0.0266	CbGeAlD
Omeprazole—CYP11A1—female gonad—testicular cancer	0.00136	0.0216	CbGeAlD
Omeprazole—CYP11A1—testis—testicular cancer	0.0012	0.0192	CbGeAlD
Omeprazole—ABCC3—female gonad—testicular cancer	0.00105	0.0168	CbGeAlD
Omeprazole—ABCG2—seminal vesicle—testicular cancer	0.00104	0.0166	CbGeAlD
Omeprazole—CYP1B1—gonad—testicular cancer	0.00101	0.0162	CbGeAlD
Omeprazole—ABCC3—testis—testicular cancer	0.000933	0.0149	CbGeAlD
Omeprazole—CYP11A1—lymph node—testicular cancer	0.000871	0.0139	CbGeAlD
Omeprazole—CYP1B1—female gonad—testicular cancer	0.000823	0.0131	CbGeAlD
Omeprazole—CYP1B1—testis—testicular cancer	0.00073	0.0116	CbGeAlD
Omeprazole—ABCC3—lymph node—testicular cancer	0.000676	0.0108	CbGeAlD
Omeprazole—ABCG2—female gonad—testicular cancer	0.000613	0.00977	CbGeAlD
Omeprazole—CYP1A1—female gonad—testicular cancer	0.000582	0.00928	CbGeAlD
Omeprazole—CYP2C8—testis—testicular cancer	0.000559	0.00892	CbGeAlD
Omeprazole—ABCB1—embryo—testicular cancer	0.000548	0.00874	CbGeAlD
Omeprazole—ABCG2—testis—testicular cancer	0.000544	0.00867	CbGeAlD
Omeprazole—CYP1B1—lymph node—testicular cancer	0.000529	0.00844	CbGeAlD
Omeprazole—ABCB1—seminal vesicle—testicular cancer	0.000515	0.00821	CbGeAlD
Omeprazole—CYP2D6—female gonad—testicular cancer	0.00042	0.0067	CbGeAlD
Omeprazole—ABCG2—lymph node—testicular cancer	0.000394	0.00628	CbGeAlD
Omeprazole—CYP1A1—lymph node—testicular cancer	0.000374	0.00597	CbGeAlD
Omeprazole—CYP2D6—testis—testicular cancer	0.000373	0.00594	CbGeAlD
Omeprazole—ABCB1—gonad—testicular cancer	0.000372	0.00593	CbGeAlD
Omeprazole—ABCB1—female gonad—testicular cancer	0.000302	0.00482	CbGeAlD
Omeprazole—ABCB1—testis—testicular cancer	0.000268	0.00427	CbGeAlD
Omeprazole—ABCB1—lymph node—testicular cancer	0.000194	0.0031	CbGeAlD
Omeprazole—Visual impairment—Methotrexate—testicular cancer	0.000109	0.000564	CcSEcCtD
Omeprazole—Stevens-Johnson syndrome—Doxorubicin—testicular cancer	0.000108	0.000559	CcSEcCtD
Omeprazole—Vomiting—Ifosfamide—testicular cancer	0.000108	0.000559	CcSEcCtD
Omeprazole—Hypersensitivity—Cisplatin—testicular cancer	0.000108	0.000558	CcSEcCtD
Omeprazole—Bradycardia—Epirubicin—testicular cancer	0.000108	0.000557	CcSEcCtD
Omeprazole—Renal failure—Doxorubicin—testicular cancer	0.000107	0.000555	CcSEcCtD
Omeprazole—Rash—Ifosfamide—testicular cancer	0.000107	0.000554	CcSEcCtD
Omeprazole—Dermatitis—Ifosfamide—testicular cancer	0.000107	0.000553	CcSEcCtD
Omeprazole—Erythema multiforme—Methotrexate—testicular cancer	0.000107	0.000553	CcSEcCtD
Omeprazole—Urticaria—Etoposide—testicular cancer	0.000107	0.000551	CcSEcCtD
Omeprazole—Stomatitis—Doxorubicin—testicular cancer	0.000106	0.00055	CcSEcCtD
Omeprazole—Jaundice—Doxorubicin—testicular cancer	0.000106	0.00055	CcSEcCtD
Omeprazole—Rhinitis—Epirubicin—testicular cancer	0.000106	0.000549	CcSEcCtD
Omeprazole—Abdominal pain—Etoposide—testicular cancer	0.000106	0.000548	CcSEcCtD
Omeprazole—Body temperature increased—Etoposide—testicular cancer	0.000106	0.000548	CcSEcCtD
Omeprazole—Conjunctivitis—Doxorubicin—testicular cancer	0.000106	0.000548	CcSEcCtD
Omeprazole—Urinary tract infection—Doxorubicin—testicular cancer	0.000106	0.000548	CcSEcCtD
Omeprazole—Hepatitis—Epirubicin—testicular cancer	0.000106	0.000547	CcSEcCtD
Omeprazole—Eye disorder—Methotrexate—testicular cancer	0.000106	0.000547	CcSEcCtD
Omeprazole—Tinnitus—Methotrexate—testicular cancer	0.000105	0.000545	CcSEcCtD
Omeprazole—Hypoaesthesia—Epirubicin—testicular cancer	0.000105	0.000545	CcSEcCtD
Omeprazole—Asthenia—Cisplatin—testicular cancer	0.000105	0.000543	CcSEcCtD
Omeprazole—Pharyngitis—Epirubicin—testicular cancer	0.000105	0.000543	CcSEcCtD
Omeprazole—Urinary tract disorder—Epirubicin—testicular cancer	0.000105	0.000541	CcSEcCtD
Omeprazole—Oedema peripheral—Epirubicin—testicular cancer	0.000104	0.000539	CcSEcCtD
Omeprazole—Haematuria—Doxorubicin—testicular cancer	0.000104	0.000538	CcSEcCtD
Omeprazole—Connective tissue disorder—Epirubicin—testicular cancer	0.000104	0.000538	CcSEcCtD
Omeprazole—Urethral disorder—Epirubicin—testicular cancer	0.000104	0.000537	CcSEcCtD
Omeprazole—Hepatobiliary disease—Doxorubicin—testicular cancer	0.000103	0.000534	CcSEcCtD
Omeprazole—Epistaxis—Doxorubicin—testicular cancer	0.000103	0.000532	CcSEcCtD
Omeprazole—Sinusitis—Doxorubicin—testicular cancer	0.000102	0.000529	CcSEcCtD
Omeprazole—Immune system disorder—Methotrexate—testicular cancer	0.000102	0.000528	CcSEcCtD
Omeprazole—Visual impairment—Epirubicin—testicular cancer	0.000102	0.000528	CcSEcCtD
Omeprazole—Mediastinal disorder—Methotrexate—testicular cancer	0.000102	0.000527	CcSEcCtD
Omeprazole—Agranulocytosis—Doxorubicin—testicular cancer	0.000102	0.000527	CcSEcCtD
Omeprazole—Chills—Methotrexate—testicular cancer	0.000101	0.000525	CcSEcCtD
Omeprazole—Nausea—Ifosfamide—testicular cancer	0.000101	0.000522	CcSEcCtD
Omeprazole—Diarrhoea—Cisplatin—testicular cancer	0.0001	0.000518	CcSEcCtD
Omeprazole—Erythema multiforme—Epirubicin—testicular cancer	0.0001	0.000518	CcSEcCtD
Omeprazole—Alopecia—Methotrexate—testicular cancer	0.0001	0.000517	CcSEcCtD
Omeprazole—Bradycardia—Doxorubicin—testicular cancer	9.97e-05	0.000516	CcSEcCtD
Omeprazole—Mental disorder—Methotrexate—testicular cancer	9.91e-05	0.000512	CcSEcCtD
Omeprazole—Eye disorder—Epirubicin—testicular cancer	9.89e-05	0.000512	CcSEcCtD
Omeprazole—Hypersensitivity—Etoposide—testicular cancer	9.89e-05	0.000511	CcSEcCtD
Omeprazole—Tinnitus—Epirubicin—testicular cancer	9.87e-05	0.00051	CcSEcCtD
Omeprazole—Malnutrition—Methotrexate—testicular cancer	9.85e-05	0.000509	CcSEcCtD
Omeprazole—Flushing—Epirubicin—testicular cancer	9.82e-05	0.000508	CcSEcCtD
Omeprazole—Rhinitis—Doxorubicin—testicular cancer	9.82e-05	0.000508	CcSEcCtD
Omeprazole—Hepatitis—Doxorubicin—testicular cancer	9.8e-05	0.000506	CcSEcCtD
Omeprazole—Hypoaesthesia—Doxorubicin—testicular cancer	9.75e-05	0.000504	CcSEcCtD
Omeprazole—Pharyngitis—Doxorubicin—testicular cancer	9.72e-05	0.000503	CcSEcCtD
Omeprazole—Urinary tract disorder—Doxorubicin—testicular cancer	9.67e-05	0.0005	CcSEcCtD
Omeprazole—Oedema peripheral—Doxorubicin—testicular cancer	9.65e-05	0.000499	CcSEcCtD
Omeprazole—Dysgeusia—Methotrexate—testicular cancer	9.64e-05	0.000499	CcSEcCtD
Omeprazole—Asthenia—Etoposide—testicular cancer	9.63e-05	0.000498	CcSEcCtD
Omeprazole—Connective tissue disorder—Doxorubicin—testicular cancer	9.63e-05	0.000498	CcSEcCtD
Omeprazole—Urethral disorder—Doxorubicin—testicular cancer	9.6e-05	0.000496	CcSEcCtD
Omeprazole—Immune system disorder—Epirubicin—testicular cancer	9.56e-05	0.000494	CcSEcCtD
Omeprazole—Mediastinal disorder—Epirubicin—testicular cancer	9.54e-05	0.000493	CcSEcCtD
Omeprazole—Back pain—Methotrexate—testicular cancer	9.53e-05	0.000493	CcSEcCtD
Omeprazole—Chills—Epirubicin—testicular cancer	9.5e-05	0.000491	CcSEcCtD
Omeprazole—Pruritus—Etoposide—testicular cancer	9.49e-05	0.000491	CcSEcCtD
Omeprazole—Visual impairment—Doxorubicin—testicular cancer	9.44e-05	0.000488	CcSEcCtD
Omeprazole—Alopecia—Epirubicin—testicular cancer	9.35e-05	0.000484	CcSEcCtD
Omeprazole—Vomiting—Cisplatin—testicular cancer	9.31e-05	0.000481	CcSEcCtD
Omeprazole—Vision blurred—Methotrexate—testicular cancer	9.28e-05	0.00048	CcSEcCtD
Omeprazole—Mental disorder—Epirubicin—testicular cancer	9.27e-05	0.00048	CcSEcCtD
Omeprazole—Erythema multiforme—Doxorubicin—testicular cancer	9.26e-05	0.000479	CcSEcCtD
Omeprazole—Rash—Cisplatin—testicular cancer	9.23e-05	0.000477	CcSEcCtD
Omeprazole—Dermatitis—Cisplatin—testicular cancer	9.23e-05	0.000477	CcSEcCtD
Omeprazole—Malnutrition—Epirubicin—testicular cancer	9.22e-05	0.000477	CcSEcCtD
Omeprazole—Diarrhoea—Etoposide—testicular cancer	9.18e-05	0.000475	CcSEcCtD
Omeprazole—Eye disorder—Doxorubicin—testicular cancer	9.15e-05	0.000473	CcSEcCtD
Omeprazole—Ill-defined disorder—Methotrexate—testicular cancer	9.14e-05	0.000472	CcSEcCtD
Omeprazole—Tinnitus—Doxorubicin—testicular cancer	9.13e-05	0.000472	CcSEcCtD
Omeprazole—Anaemia—Methotrexate—testicular cancer	9.1e-05	0.000471	CcSEcCtD
Omeprazole—Flushing—Doxorubicin—testicular cancer	9.09e-05	0.00047	CcSEcCtD
Omeprazole—Flatulence—Epirubicin—testicular cancer	9.08e-05	0.00047	CcSEcCtD
Omeprazole—Tension—Epirubicin—testicular cancer	9.04e-05	0.000468	CcSEcCtD
Omeprazole—Dysgeusia—Epirubicin—testicular cancer	9.02e-05	0.000467	CcSEcCtD
Omeprazole—Nervousness—Epirubicin—testicular cancer	8.95e-05	0.000463	CcSEcCtD
Omeprazole—Back pain—Epirubicin—testicular cancer	8.91e-05	0.000461	CcSEcCtD
Omeprazole—Malaise—Methotrexate—testicular cancer	8.88e-05	0.000459	CcSEcCtD
Omeprazole—Dizziness—Etoposide—testicular cancer	8.87e-05	0.000459	CcSEcCtD
Omeprazole—Muscle spasms—Epirubicin—testicular cancer	8.86e-05	0.000458	CcSEcCtD
Omeprazole—Immune system disorder—Doxorubicin—testicular cancer	8.85e-05	0.000457	CcSEcCtD
Omeprazole—Vertigo—Methotrexate—testicular cancer	8.85e-05	0.000457	CcSEcCtD
Omeprazole—Mediastinal disorder—Doxorubicin—testicular cancer	8.83e-05	0.000456	CcSEcCtD
Omeprazole—Leukopenia—Methotrexate—testicular cancer	8.81e-05	0.000456	CcSEcCtD
Omeprazole—Chills—Doxorubicin—testicular cancer	8.79e-05	0.000454	CcSEcCtD
Omeprazole—Nausea—Cisplatin—testicular cancer	8.7e-05	0.00045	CcSEcCtD
Omeprazole—Vision blurred—Epirubicin—testicular cancer	8.68e-05	0.000449	CcSEcCtD
Omeprazole—Alopecia—Doxorubicin—testicular cancer	8.66e-05	0.000448	CcSEcCtD
Omeprazole—Cough—Methotrexate—testicular cancer	8.59e-05	0.000444	CcSEcCtD
Omeprazole—Mental disorder—Doxorubicin—testicular cancer	8.58e-05	0.000444	CcSEcCtD
Omeprazole—Ill-defined disorder—Epirubicin—testicular cancer	8.55e-05	0.000442	CcSEcCtD
Omeprazole—Vomiting—Etoposide—testicular cancer	8.53e-05	0.000441	CcSEcCtD
Omeprazole—Malnutrition—Doxorubicin—testicular cancer	8.53e-05	0.000441	CcSEcCtD
Omeprazole—Anaemia—Epirubicin—testicular cancer	8.52e-05	0.00044	CcSEcCtD
Omeprazole—Agitation—Epirubicin—testicular cancer	8.47e-05	0.000438	CcSEcCtD
Omeprazole—Rash—Etoposide—testicular cancer	8.46e-05	0.000437	CcSEcCtD
Omeprazole—Dermatitis—Etoposide—testicular cancer	8.45e-05	0.000437	CcSEcCtD
Omeprazole—Headache—Etoposide—testicular cancer	8.41e-05	0.000435	CcSEcCtD
Omeprazole—Flatulence—Doxorubicin—testicular cancer	8.4e-05	0.000434	CcSEcCtD
Omeprazole—Myalgia—Methotrexate—testicular cancer	8.38e-05	0.000433	CcSEcCtD
Omeprazole—Chest pain—Methotrexate—testicular cancer	8.38e-05	0.000433	CcSEcCtD
Omeprazole—Arthralgia—Methotrexate—testicular cancer	8.38e-05	0.000433	CcSEcCtD
Omeprazole—Tension—Doxorubicin—testicular cancer	8.37e-05	0.000433	CcSEcCtD
Omeprazole—Dysgeusia—Doxorubicin—testicular cancer	8.35e-05	0.000432	CcSEcCtD
Omeprazole—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—testicular cancer	8.33e-05	0.000431	CcSEcCtD
Omeprazole—Malaise—Epirubicin—testicular cancer	8.31e-05	0.00043	CcSEcCtD
Omeprazole—Discomfort—Methotrexate—testicular cancer	8.28e-05	0.000428	CcSEcCtD
Omeprazole—Nervousness—Doxorubicin—testicular cancer	8.28e-05	0.000428	CcSEcCtD
Omeprazole—Vertigo—Epirubicin—testicular cancer	8.28e-05	0.000428	CcSEcCtD
Omeprazole—Leukopenia—Epirubicin—testicular cancer	8.25e-05	0.000427	CcSEcCtD
Omeprazole—Back pain—Doxorubicin—testicular cancer	8.25e-05	0.000426	CcSEcCtD
Omeprazole—Muscle spasms—Doxorubicin—testicular cancer	8.2e-05	0.000424	CcSEcCtD
Omeprazole—Palpitations—Epirubicin—testicular cancer	8.14e-05	0.000421	CcSEcCtD
Omeprazole—Confusional state—Methotrexate—testicular cancer	8.1e-05	0.000419	CcSEcCtD
Omeprazole—Cough—Epirubicin—testicular cancer	8.04e-05	0.000416	CcSEcCtD
Omeprazole—Anaphylactic shock—Methotrexate—testicular cancer	8.04e-05	0.000416	CcSEcCtD
Omeprazole—Vision blurred—Doxorubicin—testicular cancer	8.04e-05	0.000416	CcSEcCtD
Omeprazole—Infection—Methotrexate—testicular cancer	7.98e-05	0.000413	CcSEcCtD
Omeprazole—Nausea—Etoposide—testicular cancer	7.97e-05	0.000412	CcSEcCtD
Omeprazole—Hypertension—Epirubicin—testicular cancer	7.96e-05	0.000411	CcSEcCtD
Omeprazole—Ill-defined disorder—Doxorubicin—testicular cancer	7.91e-05	0.000409	CcSEcCtD
Omeprazole—Nervous system disorder—Methotrexate—testicular cancer	7.88e-05	0.000408	CcSEcCtD
Omeprazole—Anaemia—Doxorubicin—testicular cancer	7.88e-05	0.000408	CcSEcCtD
Omeprazole—Thrombocytopenia—Methotrexate—testicular cancer	7.87e-05	0.000407	CcSEcCtD
Omeprazole—Chest pain—Epirubicin—testicular cancer	7.85e-05	0.000406	CcSEcCtD
Omeprazole—Arthralgia—Epirubicin—testicular cancer	7.85e-05	0.000406	CcSEcCtD
Omeprazole—Myalgia—Epirubicin—testicular cancer	7.85e-05	0.000406	CcSEcCtD
Omeprazole—Agitation—Doxorubicin—testicular cancer	7.84e-05	0.000405	CcSEcCtD
Omeprazole—Anxiety—Epirubicin—testicular cancer	7.82e-05	0.000404	CcSEcCtD
Omeprazole—Skin disorder—Methotrexate—testicular cancer	7.81e-05	0.000404	CcSEcCtD
Omeprazole—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—testicular cancer	7.79e-05	0.000403	CcSEcCtD
Omeprazole—Hyperhidrosis—Methotrexate—testicular cancer	7.77e-05	0.000402	CcSEcCtD
Omeprazole—Discomfort—Epirubicin—testicular cancer	7.75e-05	0.000401	CcSEcCtD
Omeprazole—Malaise—Doxorubicin—testicular cancer	7.69e-05	0.000398	CcSEcCtD
Omeprazole—Dry mouth—Epirubicin—testicular cancer	7.67e-05	0.000397	CcSEcCtD
Omeprazole—Vertigo—Doxorubicin—testicular cancer	7.66e-05	0.000396	CcSEcCtD
Omeprazole—Anorexia—Methotrexate—testicular cancer	7.66e-05	0.000396	CcSEcCtD
Omeprazole—Leukopenia—Doxorubicin—testicular cancer	7.63e-05	0.000395	CcSEcCtD
Omeprazole—Confusional state—Epirubicin—testicular cancer	7.58e-05	0.000392	CcSEcCtD
Omeprazole—Palpitations—Doxorubicin—testicular cancer	7.54e-05	0.00039	CcSEcCtD
Omeprazole—Anaphylactic shock—Epirubicin—testicular cancer	7.52e-05	0.000389	CcSEcCtD
Omeprazole—Infection—Epirubicin—testicular cancer	7.47e-05	0.000386	CcSEcCtD
Omeprazole—Cough—Doxorubicin—testicular cancer	7.44e-05	0.000385	CcSEcCtD
Omeprazole—Shock—Epirubicin—testicular cancer	7.4e-05	0.000383	CcSEcCtD
Omeprazole—Nervous system disorder—Epirubicin—testicular cancer	7.38e-05	0.000381	CcSEcCtD
Omeprazole—Thrombocytopenia—Epirubicin—testicular cancer	7.36e-05	0.000381	CcSEcCtD
Omeprazole—Hypertension—Doxorubicin—testicular cancer	7.36e-05	0.000381	CcSEcCtD
Omeprazole—Tachycardia—Epirubicin—testicular cancer	7.34e-05	0.00038	CcSEcCtD
Omeprazole—Musculoskeletal discomfort—Methotrexate—testicular cancer	7.32e-05	0.000379	CcSEcCtD
Omeprazole—Skin disorder—Epirubicin—testicular cancer	7.31e-05	0.000378	CcSEcCtD
Omeprazole—Hyperhidrosis—Epirubicin—testicular cancer	7.27e-05	0.000376	CcSEcCtD
Omeprazole—Insomnia—Methotrexate—testicular cancer	7.27e-05	0.000376	CcSEcCtD
Omeprazole—Arthralgia—Doxorubicin—testicular cancer	7.26e-05	0.000375	CcSEcCtD
Omeprazole—Myalgia—Doxorubicin—testicular cancer	7.26e-05	0.000375	CcSEcCtD
Omeprazole—Chest pain—Doxorubicin—testicular cancer	7.26e-05	0.000375	CcSEcCtD
Omeprazole—Anxiety—Doxorubicin—testicular cancer	7.23e-05	0.000374	CcSEcCtD
Omeprazole—Paraesthesia—Methotrexate—testicular cancer	7.22e-05	0.000373	CcSEcCtD
Omeprazole—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—testicular cancer	7.21e-05	0.000373	CcSEcCtD
Omeprazole—Discomfort—Doxorubicin—testicular cancer	7.17e-05	0.000371	CcSEcCtD
Omeprazole—Anorexia—Epirubicin—testicular cancer	7.17e-05	0.000371	CcSEcCtD
Omeprazole—Dyspnoea—Methotrexate—testicular cancer	7.17e-05	0.00037	CcSEcCtD
Omeprazole—Somnolence—Methotrexate—testicular cancer	7.14e-05	0.000369	CcSEcCtD
Omeprazole—Dry mouth—Doxorubicin—testicular cancer	7.1e-05	0.000367	CcSEcCtD
Omeprazole—Dyspepsia—Methotrexate—testicular cancer	7.07e-05	0.000366	CcSEcCtD
Omeprazole—Confusional state—Doxorubicin—testicular cancer	7.02e-05	0.000363	CcSEcCtD
Omeprazole—Decreased appetite—Methotrexate—testicular cancer	6.99e-05	0.000361	CcSEcCtD
Omeprazole—Anaphylactic shock—Doxorubicin—testicular cancer	6.96e-05	0.00036	CcSEcCtD
Omeprazole—Gastrointestinal disorder—Methotrexate—testicular cancer	6.94e-05	0.000359	CcSEcCtD
Omeprazole—Fatigue—Methotrexate—testicular cancer	6.93e-05	0.000358	CcSEcCtD
Omeprazole—Infection—Doxorubicin—testicular cancer	6.91e-05	0.000357	CcSEcCtD
Omeprazole—Pain—Methotrexate—testicular cancer	6.87e-05	0.000355	CcSEcCtD
Omeprazole—Musculoskeletal discomfort—Epirubicin—testicular cancer	6.85e-05	0.000354	CcSEcCtD
Omeprazole—Shock—Doxorubicin—testicular cancer	6.85e-05	0.000354	CcSEcCtD
Omeprazole—Nervous system disorder—Doxorubicin—testicular cancer	6.82e-05	0.000353	CcSEcCtD
Omeprazole—Thrombocytopenia—Doxorubicin—testicular cancer	6.81e-05	0.000352	CcSEcCtD
Omeprazole—Insomnia—Epirubicin—testicular cancer	6.8e-05	0.000352	CcSEcCtD
Omeprazole—Tachycardia—Doxorubicin—testicular cancer	6.79e-05	0.000351	CcSEcCtD
Omeprazole—Skin disorder—Doxorubicin—testicular cancer	6.76e-05	0.00035	CcSEcCtD
Omeprazole—Paraesthesia—Epirubicin—testicular cancer	6.75e-05	0.000349	CcSEcCtD
Omeprazole—Hyperhidrosis—Doxorubicin—testicular cancer	6.73e-05	0.000348	CcSEcCtD
Omeprazole—Dyspnoea—Epirubicin—testicular cancer	6.71e-05	0.000347	CcSEcCtD
Omeprazole—Somnolence—Epirubicin—testicular cancer	6.69e-05	0.000346	CcSEcCtD
Omeprazole—Anorexia—Doxorubicin—testicular cancer	6.63e-05	0.000343	CcSEcCtD
Omeprazole—Feeling abnormal—Methotrexate—testicular cancer	6.62e-05	0.000342	CcSEcCtD
Omeprazole—Dyspepsia—Epirubicin—testicular cancer	6.62e-05	0.000342	CcSEcCtD
Omeprazole—Gastrointestinal pain—Methotrexate—testicular cancer	6.57e-05	0.00034	CcSEcCtD
Omeprazole—Decreased appetite—Epirubicin—testicular cancer	6.54e-05	0.000338	CcSEcCtD
Omeprazole—Gastrointestinal disorder—Epirubicin—testicular cancer	6.49e-05	0.000336	CcSEcCtD
Omeprazole—Fatigue—Epirubicin—testicular cancer	6.48e-05	0.000335	CcSEcCtD
Omeprazole—Constipation—Epirubicin—testicular cancer	6.43e-05	0.000333	CcSEcCtD
Omeprazole—Pain—Epirubicin—testicular cancer	6.43e-05	0.000333	CcSEcCtD
Omeprazole—Urticaria—Methotrexate—testicular cancer	6.38e-05	0.00033	CcSEcCtD
Omeprazole—Body temperature increased—Methotrexate—testicular cancer	6.35e-05	0.000329	CcSEcCtD
Omeprazole—Abdominal pain—Methotrexate—testicular cancer	6.35e-05	0.000329	CcSEcCtD
Omeprazole—Musculoskeletal discomfort—Doxorubicin—testicular cancer	6.34e-05	0.000328	CcSEcCtD
Omeprazole—Insomnia—Doxorubicin—testicular cancer	6.29e-05	0.000325	CcSEcCtD
Omeprazole—Paraesthesia—Doxorubicin—testicular cancer	6.25e-05	0.000323	CcSEcCtD
Omeprazole—Dyspnoea—Doxorubicin—testicular cancer	6.2e-05	0.000321	CcSEcCtD
Omeprazole—Feeling abnormal—Epirubicin—testicular cancer	6.2e-05	0.00032	CcSEcCtD
Omeprazole—Somnolence—Doxorubicin—testicular cancer	6.19e-05	0.00032	CcSEcCtD
Omeprazole—Gastrointestinal pain—Epirubicin—testicular cancer	6.15e-05	0.000318	CcSEcCtD
Omeprazole—Dyspepsia—Doxorubicin—testicular cancer	6.13e-05	0.000317	CcSEcCtD
Omeprazole—Decreased appetite—Doxorubicin—testicular cancer	6.05e-05	0.000313	CcSEcCtD
Omeprazole—Gastrointestinal disorder—Doxorubicin—testicular cancer	6.01e-05	0.000311	CcSEcCtD
Omeprazole—Fatigue—Doxorubicin—testicular cancer	6e-05	0.00031	CcSEcCtD
Omeprazole—Urticaria—Epirubicin—testicular cancer	5.97e-05	0.000309	CcSEcCtD
Omeprazole—Pain—Doxorubicin—testicular cancer	5.95e-05	0.000308	CcSEcCtD
Omeprazole—Constipation—Doxorubicin—testicular cancer	5.95e-05	0.000308	CcSEcCtD
Omeprazole—Abdominal pain—Epirubicin—testicular cancer	5.95e-05	0.000307	CcSEcCtD
Omeprazole—Body temperature increased—Epirubicin—testicular cancer	5.95e-05	0.000307	CcSEcCtD
Omeprazole—Hypersensitivity—Methotrexate—testicular cancer	5.92e-05	0.000306	CcSEcCtD
Omeprazole—Asthenia—Methotrexate—testicular cancer	5.77e-05	0.000298	CcSEcCtD
Omeprazole—Feeling abnormal—Doxorubicin—testicular cancer	5.73e-05	0.000297	CcSEcCtD
Omeprazole—Gastrointestinal pain—Doxorubicin—testicular cancer	5.69e-05	0.000294	CcSEcCtD
Omeprazole—Pruritus—Methotrexate—testicular cancer	5.69e-05	0.000294	CcSEcCtD
Omeprazole—Hypersensitivity—Epirubicin—testicular cancer	5.54e-05	0.000287	CcSEcCtD
Omeprazole—Urticaria—Doxorubicin—testicular cancer	5.53e-05	0.000286	CcSEcCtD
Omeprazole—Abdominal pain—Doxorubicin—testicular cancer	5.5e-05	0.000284	CcSEcCtD
Omeprazole—Body temperature increased—Doxorubicin—testicular cancer	5.5e-05	0.000284	CcSEcCtD
Omeprazole—Diarrhoea—Methotrexate—testicular cancer	5.5e-05	0.000284	CcSEcCtD
Omeprazole—Asthenia—Epirubicin—testicular cancer	5.4e-05	0.000279	CcSEcCtD
Omeprazole—Pruritus—Epirubicin—testicular cancer	5.32e-05	0.000275	CcSEcCtD
Omeprazole—Dizziness—Methotrexate—testicular cancer	5.31e-05	0.000275	CcSEcCtD
Omeprazole—Diarrhoea—Epirubicin—testicular cancer	5.15e-05	0.000266	CcSEcCtD
Omeprazole—Hypersensitivity—Doxorubicin—testicular cancer	5.13e-05	0.000265	CcSEcCtD
Omeprazole—Vomiting—Methotrexate—testicular cancer	5.11e-05	0.000264	CcSEcCtD
Omeprazole—Rash—Methotrexate—testicular cancer	5.07e-05	0.000262	CcSEcCtD
Omeprazole—Dermatitis—Methotrexate—testicular cancer	5.06e-05	0.000262	CcSEcCtD
Omeprazole—Headache—Methotrexate—testicular cancer	5.03e-05	0.00026	CcSEcCtD
Omeprazole—Asthenia—Doxorubicin—testicular cancer	4.99e-05	0.000258	CcSEcCtD
Omeprazole—Dizziness—Epirubicin—testicular cancer	4.97e-05	0.000257	CcSEcCtD
Omeprazole—Pruritus—Doxorubicin—testicular cancer	4.92e-05	0.000255	CcSEcCtD
Omeprazole—Vomiting—Epirubicin—testicular cancer	4.78e-05	0.000247	CcSEcCtD
Omeprazole—Nausea—Methotrexate—testicular cancer	4.77e-05	0.000247	CcSEcCtD
Omeprazole—Diarrhoea—Doxorubicin—testicular cancer	4.76e-05	0.000246	CcSEcCtD
Omeprazole—Rash—Epirubicin—testicular cancer	4.74e-05	0.000245	CcSEcCtD
Omeprazole—Dermatitis—Epirubicin—testicular cancer	4.74e-05	0.000245	CcSEcCtD
Omeprazole—Headache—Epirubicin—testicular cancer	4.71e-05	0.000244	CcSEcCtD
Omeprazole—Dizziness—Doxorubicin—testicular cancer	4.6e-05	0.000238	CcSEcCtD
Omeprazole—Nausea—Epirubicin—testicular cancer	4.47e-05	0.000231	CcSEcCtD
Omeprazole—Vomiting—Doxorubicin—testicular cancer	4.42e-05	0.000229	CcSEcCtD
Omeprazole—Rash—Doxorubicin—testicular cancer	4.39e-05	0.000227	CcSEcCtD
Omeprazole—Dermatitis—Doxorubicin—testicular cancer	4.38e-05	0.000227	CcSEcCtD
Omeprazole—Headache—Doxorubicin—testicular cancer	4.36e-05	0.000225	CcSEcCtD
Omeprazole—Nausea—Doxorubicin—testicular cancer	4.13e-05	0.000214	CcSEcCtD
